Back
Ardelyx Vs. Karyopharm Therapeutics Industry Stock Comparison
Buy
53
ARDX
Ardelyx
Last Price:
7.63
Seasonality Move:
-7.28%
Sell
50
KPTI
Karyopharm Therapeutics
Last Price:
1.08
Seasonality Move:
-3.19%
Buy
53
Ardelyx (ARDX)
is a Buy
Is Ardelyx a Buy, Sell or Hold?
- The current Ardelyx [ARDX] share price is $8.07. The Score for ARDX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- ARDX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
Karyopharm Therapeutics (KPTI)
is a Sell
Is Karyopharm Therapeutics a Buy, Sell or Hold?
- The current Karyopharm Therapeutics [KPTI] share price is $1.06. The Score for KPTI is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- KPTI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ARDX Stock Price Chart
KPTI Stock Price Chart
What is Karyopharm Therapeutics's stock price today?
-
The Karyopharm Therapeutics share price today is $1.06
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KPTI is experiencing slight buying pressure.
ARDX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.28 | Buy |
| Relative Strength Index (14 RSI): | 56.99 | Buy |
| Chaikin Money Flow: | -2863618 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.25 - 8.03) | Buy |
| Bollinger Bands (100): | (6.77 - 9.09) | Buy |
KPTI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 42.78 | Sell |
| Chaikin Money Flow: | 132068 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.05 - 1.27) | Sell |
| Bollinger Bands (100): | (0.88 - 1.4) | Sell |
ARDX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.94 | Buy |
| 20-day SMA: | 7.1 | Buy |
| 50-day SMA: | 7.66 | Buy |
| 200-day SMA: | 6.02 | Buy |
| 8-day EMA: | 8.04 | Buy |
| 20-day EMA: | 7.53 | Buy |
| 50-day EMA: | 7.55 | Buy |
| 200-day EMA: | 6.38 | Buy |
KPTI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.08 | Sell |
| 20-day SMA: | 1.12 | Sell |
| 50-day SMA: | 1.28 | Sell |
| 200-day SMA: | 1.16 | Sell |
| 8-day EMA: | 1.08 | Sell |
| 20-day EMA: | 1.14 | Sell |
| 50-day EMA: | 1.2 | Sell |
| 200-day EMA: | 1.45 | Sell |
Ardelyx Earnings Growth & ARDX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.11 per share, a decrease this year of $0.10 per share, and an increase next year of $0.47 per share.
Karyopharm Therapeutics Earnings Growth & KPTI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.06 per share, an increase this year of $0.00 per share, and an increase next year of $0.22 per share.
Ardelyx Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Karyopharm Therapeutics Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||